1.Clinical Comprehensive Evaluation of MRSA Treatment Drugs in Artificial Joint Infection
Xinru LIU ; Menglu LI ; Jinhong GONG ; Yuji WANG ; Dan SU ; Xindie ZHOU ; JingJing SHANG
Herald of Medicine 2025;44(3):422-428
Objective To evaluate the comprehensive value of methicillin-resistant Staphylococcus aureus(MRSA)treatment drugs in artificial joint infections from multiple perspectives and to solve the problem of MRSA infections in artificial joints.Methods Through literature research,relevant literature was retrieved and clinical studies meeting the requirements were selected and summarized.The Analytic Hierarchy Process(AHP)was applied to collect comprehensive clinical evaluation evidence and to conduct evaluations across different dimensions according to evaluation guidelines;the Delphi method combined with AHP was used for expert anonymous questionnaire evaluation,and the data was compared and analyzed.Results A clini-cal comprehensive evaluation index model for the treatment of artificial joint infections was successfully established,and the yaahp analysis software was used to score the comprehensive clinical evaluation evidence in various directions.Treatment drugs,vancomy-cin,daptomycin,and linezolid,at various levels were calculated through the software,and it was concluded that linezolid has the highest clinical comprehensive evaluation score.Conclusion Among the treatment drugs for MRSA infections in artificial joints,linezolid has a higher clinical comprehensive value and can provide a reference for the clinical treatment of MRSA infec-tions in artificial joints.
2.The effect of inflammation on the outcome of assisted conception in patients with endometriosis
Wenxia LIU ; Rusi LUO ; Bijun WANG ; Fangfang LIANG ; Xiaodan WANG ; Menglu JI ; Jiaheng LI ; Bingnan REN ; Yichun GUAN
China Modern Doctor 2025;63(28):1-4,22
Objective To exploring the effect of inflammatory indicators on the outcome of assisted conception of in vitro fertilization/intracytoplasmic sperm injection(IVF/ICSI)in patients with ovarian endometriosis(OEM).Methods The study subjects were selected as the patients with OEM who received IVF/ICSI treatment at the Third Affiliated Hospital of Zhengzhou University from January 2019 to February 2024.Based on whether previous surgery for uterine endometriosis cyst removal had been performed,they were divided into non-surgery group(n=73)and surgery group(n=112).To explore the differences in inflammatory markers between two groups and to determine whether they have an impact on the outcome of assisted reproduction.Results The lymphocytes(L)and blastocyst formation rates of patients in surgery group were significantly higher than those in non-surgery group,platelet to lymphocyte ratio(PLR)and carbohydrate antigen 125(CA125)were significantly lower than those in non-surgery group(P<0.05).There were no statistically significant differences in the clinical pregnancy rate and live birth rate between two groups of patients(P>0.05).After adjusting for confounding factors,the results of multivariate Logistic regression analysis showed that L,PLR,and CA125 had no statistically significant impact on the clinical pregnancy rate and live birth rate(P>0.05).Both maternal age and the number of embryos transferred exerted a certain influence on clinical pregnancy rates and live birth rates(P<0.05),furthermore,the type of embryo transferred had a significant effect on clinical pregnancy rates(P<0.05).Conclusion Compared with non-surgery group,surgery group had higher L level and lower PRL and CA125 levels,but these changes did not significantly affect clinical pregnancy or live birth outcomes in OEM patients undergoing IVF/ICSI assisted reproduction.
3.The effect of inflammation on the outcome of assisted conception in patients with endometriosis
Wenxia LIU ; Rusi LUO ; Bijun WANG ; Fangfang LIANG ; Xiaodan WANG ; Menglu JI ; Jiaheng LI ; Bingnan REN ; Yichun GUAN
China Modern Doctor 2025;63(28):1-4,22
Objective To exploring the effect of inflammatory indicators on the outcome of assisted conception of in vitro fertilization/intracytoplasmic sperm injection(IVF/ICSI)in patients with ovarian endometriosis(OEM).Methods The study subjects were selected as the patients with OEM who received IVF/ICSI treatment at the Third Affiliated Hospital of Zhengzhou University from January 2019 to February 2024.Based on whether previous surgery for uterine endometriosis cyst removal had been performed,they were divided into non-surgery group(n=73)and surgery group(n=112).To explore the differences in inflammatory markers between two groups and to determine whether they have an impact on the outcome of assisted reproduction.Results The lymphocytes(L)and blastocyst formation rates of patients in surgery group were significantly higher than those in non-surgery group,platelet to lymphocyte ratio(PLR)and carbohydrate antigen 125(CA125)were significantly lower than those in non-surgery group(P<0.05).There were no statistically significant differences in the clinical pregnancy rate and live birth rate between two groups of patients(P>0.05).After adjusting for confounding factors,the results of multivariate Logistic regression analysis showed that L,PLR,and CA125 had no statistically significant impact on the clinical pregnancy rate and live birth rate(P>0.05).Both maternal age and the number of embryos transferred exerted a certain influence on clinical pregnancy rates and live birth rates(P<0.05),furthermore,the type of embryo transferred had a significant effect on clinical pregnancy rates(P<0.05).Conclusion Compared with non-surgery group,surgery group had higher L level and lower PRL and CA125 levels,but these changes did not significantly affect clinical pregnancy or live birth outcomes in OEM patients undergoing IVF/ICSI assisted reproduction.
4.Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study
Kailun YAN ; Jiawen LI ; Kexin ZHANG ; Menglu LIU ; Pei ZHU ; Xiaofang TANG ; Deshan YUAN ; Yuejin YANG ; Runlin GAO ; Jinqing YUAN ; Xueyan ZHAO
Endocrinology and Metabolism 2025;40(6):904-915
Background:
Apolipoprotein A-I (ApoA-I) is a key cardioprotective lipoprotein. Nevertheless, it remains unclear how ApoA-I relates to ischemic risk across glucose metabolism statuses in patients with coronary artery disease (CAD). This study investigated whether glucose metabolism status influences the association between ApoA-I and ischemic risk in CAD patients.
Methods:
This cohort study included 10,724 consecutive CAD patients undergoing percutaneous coronary intervention, who were classified into diabetes mellitus (DM), pre-DM, and normal glucose regulation (NGR) groups. The primary clinical endpoint was major adverse cardiac and cerebrovascular event (MACCE), defined as a composite of all-cause death, myocardial infarction, revascularization, and stroke.
Results:
Of the 10,232 patients ultimately included, 2,139 (20.9%) experienced MACCE over 5 years. A significant interaction was observed between ApoA-I levels and glucose metabolism status (P for interaction=0.041). In the DM group, an L-shaped association between ApoA-I and MACCE was found, with lower ApoA-I levels linked to a higher risk of MACCE (P for non-linearity= 0.044). Multivariate Cox regression analysis showed that patients in the lowest quintile of ApoA-I had a 1.327-fold increased risk of MACCE compared to those at the lowest risk (hazard ratio, 1.327; 95% confidence interval, 1.097 to 1.604). However, no significant association was observed in the pre-DM or NGR groups (both P>0.05).
Conclusion
This large-scale, 5-year follow-up study is the first to demonstrate that lower ApoA-I levels are associated with increased MACCE risk in CAD patients with DM, highlighting the potential value of ApoA-I in risk stratification and as a therapeutic target.
5.Clinical Comprehensive Evaluation of MRSA Treatment Drugs in Artificial Joint Infection
Xinru LIU ; Menglu LI ; Jinhong GONG ; Yuji WANG ; Dan SU ; Xindie ZHOU ; JingJing SHANG
Herald of Medicine 2025;44(3):422-428
Objective To evaluate the comprehensive value of methicillin-resistant Staphylococcus aureus(MRSA)treatment drugs in artificial joint infections from multiple perspectives and to solve the problem of MRSA infections in artificial joints.Methods Through literature research,relevant literature was retrieved and clinical studies meeting the requirements were selected and summarized.The Analytic Hierarchy Process(AHP)was applied to collect comprehensive clinical evaluation evidence and to conduct evaluations across different dimensions according to evaluation guidelines;the Delphi method combined with AHP was used for expert anonymous questionnaire evaluation,and the data was compared and analyzed.Results A clini-cal comprehensive evaluation index model for the treatment of artificial joint infections was successfully established,and the yaahp analysis software was used to score the comprehensive clinical evaluation evidence in various directions.Treatment drugs,vancomy-cin,daptomycin,and linezolid,at various levels were calculated through the software,and it was concluded that linezolid has the highest clinical comprehensive evaluation score.Conclusion Among the treatment drugs for MRSA infections in artificial joints,linezolid has a higher clinical comprehensive value and can provide a reference for the clinical treatment of MRSA infec-tions in artificial joints.
6.Gastrin-releasing peptide receptor targeted PET imaging of 68Ga-DOTA-PEG 4-BBN for prostate cancer
Jiaqi YUAN ; Yaxi LI ; Dujuan LIU ; Ran REN ; Menglu LI ; Ninghan FENG ; Jianming NI
Chinese Journal of Nuclear Medicine and Molecular Imaging 2024;44(5):303-308
Objective:To design and develop a molecular imaging probe of 68Ga-labeled bombesin (BBN) analogue, 68Ga-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)-polyethylene glycol (PEG) 4-BBN, and investigate its potential to target prostate cancer with high expression of gastrin-releasing peptide receptor (GRPR) while minimizing uptake in pancreatic tissue. Methods:Based on the amino acid sequence of BBN peptides, the precursor DOTA-PEG 4-BBN was designed and prepared, followed by labeling with 68Ga and conducting to quality control analysis. The tumor uptake of 68Ga-DOTA-PEG 4-BBN was assessed by microPET/CT imaging on tumor-bearing nude mice models with PC3 of high GRPR expression or HT29 of low GRPR expression (3 mice per group). 68Ga-DOTA-PEG 4-BBN microPET/CT imaging was also performed on 6 tumor-bearing nude mice models with PC3, among which 3 mice were treated with gastrin-releasing peptide antagonist 1 h prior to injection of the tracer (blocked group). After imaging, the ex vivo tissues of 3 PC3 tumor-bearing nude mice of the non-blocked group were examined for radioactivity counting to evaluation the biodistribution of 68Ga-DOTA-PEG 4-BBN, and the percentage injected dose per gram of tissue (%ID/g) was calculated. Independent-sample t test was used for data analysis. Results:The synthesis of 68Ga-DOTA-PEG 4-BBN took 40 min, with the radiochemical yield of 50%-60% (no decay correction) and the radiochemical purity of over 95%. After incubation in the serum at 37 ℃ for 4 h, the radiochemical purity remained more than 95%. The microPET/CT imaging results indicated that the uptake in the PC3 tumor was 3.2 times higher than the uptake in the tumor after GRPR blockade ((1.34±0.24) vs (0.42±0.03) %ID/g; t=5.47, P=0.005). After the injection of 68Ga-DOTA-PEG 4-BBN at 1 h and following imaging for 15 min, the PC3 tumor-bearing nude mice models of the non-blocked group showed that the pancreatic uptake ((0.150±0.058) %ID/g) was significantly lower than that in kidneys, lungs and liver ((9.452±0.234), (0.720±0.041), (1.572±0.213) %ID/g) with a profound statistical distinction ( t values: 11.28-53.02, all P<0.001). The tumor/pancreas uptake ratio could reach 16.92 in the tumor-bearing nude mice models with high GRPR expression. Conclusion:A novel molecular imaging probe 68Ga-DOTA-PEG 4-BBN demonstrates specific recognition of tumors with high GRPR expression while exhibiting low uptake in the pancreas, which shows its potential in prostate cancer molecular imaging.
7.Application of digital teaching system in the teaching of onlay abutment teeth preparation
Xia ZHOU ; Yuran PENG ; Rui LIU ; Dongquan PU ; Menglu HU ; Kaikai HU
Chinese Journal of Medical Education Research 2024;23(6):841-846
Objective:To investigate the application of digital teaching system in the teaching of onlay abutment teeth preparation for trainees receiving standardized residency training of stomatology (abbreviated as "resident trainees").Methods:The digital simulation teaching system unit was established by using the tissue morphology memory characteristics of 3Shape Trios oral scanner and Geomagic Control X 3D imaging design software. Eighteen resident trainees from the Daping Hospital were randomly divided into two groups, nine in the control group, preparing the onlay resin tooth model independently after taking the routine PPT + demonstration operation teaching; the other nine in the test group, preparing onlay model after learning digitization teaching system unit. All resident trainees prepared on three models respectively. After the teaching, the amounts of preparation and polymerization degree were compared between the two groups, making a summary teaching evaluation. Amounts of preparation, polymerization degree and teaching satisfaction were tested by independent-samples t-test with software SPSS 21.0. Results:Compared with the resident trainees in control group, the t values of width difference of buccal shoulder, lingual shoulder, proximal middle shoulder and distal middle shoulder, height difference of functional cusp and the lowest part of the proximal middle fossa, and degree of buccal polymerization, lingual polymerization and distal polymerization were 6.21, 6.12, 3.83, 4.73, 3.73, 4.79, 8.35, 4.35, and 6.69 respectively , while P values were respectively as <0.001, <0.001, <0.001, <0.001, 0.001, <0.001, <0.001, <0.001, and <0.001, with statistical difference ( P<0.05) . The t values of height difference of non-functional cusp, the lowest part of the distal middle fossa and degree of proximal polymerization were 1.02, 1.97, and 1.43, while P values were respectively 0.312, 0.054, and 0.158, with no statistical difference ( P>0.05). All indicators of teaching satisfaction were statistically significant ( P<0.05). Conclusions:The application of digital teaching system is conducive to improving the onlay abutment teeth preparation level of residents with high teaching satisfaction, which is worth promoting in clinical practice.
8.Analysis of risk factors for iatrogenic pseudoaneurysm after cardiovascular interventional procedures
Guoyun WANG ; Huangzhuonan CHEN ; Zhihui WU ; Menglu BI ; Hexiu LIU ; Nina QU ; Xiaoli CAO
Journal of Interventional Radiology 2024;33(6):646-650
Objective To analyze the risk factors for iatrogenic pseudoaneurysm(PSA)occurring after cardiovascular interventional procedures.Methods The clinical data of 48 patients,who developed PSA after receiving cardiovascular interventional procedure at the Yantai Yuhuangding Hospital of China between January 2018 and December 2022,were retrospectively analyzed.The control group included 192 patients who had no PSA.At a case-control ratio of 1∶4,the PSA patients and non-PSA patients were paired,and the paired indicators included age,and puncture site.Univariate and multivariate logistic regression analyses were used to analyze the patients'basic data,hematological examination,and situation of the interventional procedure,and the independent risk factors were screened out.Results Multivariate logistic regression analysis showed that the high body mass index(BMI,OR=1.324,95%CI=1.097-1.598,P=0.003),smoking history(OR=4.477,95%CI=1.599-12.536,P=0.004),use of antiplatelet agents(OR=4.861,95%CI=1.018-23.214,P=0.047),combination use of antiplatelet and anticoagulant(OR=26.994,95%CI=2.353-309.686,P=0.008),the operator of the interventional procedure being an attending physician(OR=5.817,95%CI=1.139-29.717,P=0.034),low haemoglobin level(OR=0.946,95%CI=0.922-0.971,P<0.01),elevated D-dimer level(OR=2.407,95%CI=1.367-4.239,P=0.002),long-time interventional operation(OR=1.019,95%CI=1.005-1.033,P=0.009),and sheath size>6 F(OR=4.368,95%CI=1.196-15.947,P=0.026)were the independent risk factors for PSA occurring after cardiovascular interventional surgery.Conclusion High BMI,smoking history,use of antiplatelet agents,combination use of antiplatelet and anticoagulant,the operator of the interventional procedure being an attending physician,low haemoglobin level,elevated D-dimer level,long-time interventional operation,and sheath size>6 F are the independent risk factors for PSA occurring after cardiovascular interventional procedure,which can provide a basis for the early prevention of PSA.(J Intervent Radiol,2024,33:646-650)
9.Platelet Glycoprotein Ⅵ: A Novel Target for Antithrombotic Therapy in Cardiovascular Disease
Cardiology Discovery 2024;04(4):309-318
Platelets play an important role in thrombosis caused by acute coronary syndrome and stroke. As the main platelet collagen receptor, platelet glycoprotein Ⅵ (GPⅥ) is an important modulator in the activation and aggregation of platelets at vascular injury sites. Recently, GPⅥ has been identified as a potent antithrombotic target. The structure, properties, functions, and downstream signaling of GPⅥ are reviewed; its relationship with bleeding, thrombosis, and other diseases are discussed; and potential of GPⅥ as a future antiplatelet therapeutic target is summarized in this article.
10.Platelet Glycoprotein Ⅵ: A Novel Target for Antithrombotic Therapy in Cardiovascular Disease
Cardiology Discovery 2024;04(4):309-318
Platelets play an important role in thrombosis caused by acute coronary syndrome and stroke. As the main platelet collagen receptor, platelet glycoprotein Ⅵ (GPⅥ) is an important modulator in the activation and aggregation of platelets at vascular injury sites. Recently, GPⅥ has been identified as a potent antithrombotic target. The structure, properties, functions, and downstream signaling of GPⅥ are reviewed; its relationship with bleeding, thrombosis, and other diseases are discussed; and potential of GPⅥ as a future antiplatelet therapeutic target is summarized in this article.

Result Analysis
Print
Save
E-mail